These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8257131)

  • 1. Effects of cardiopulmonary bypass surgery on intravenous ciprofloxacin disposition.
    Pryka RD; Rodvold KA; Ting W; Levitsky S; Frost RW; Lettieri JT
    Antimicrob Agents Chemother; 1993 Oct; 37(10):2106-11. PubMed ID: 8257131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penetration of ciprofloxacin into heart valves, myocardium, mediastinal fat, and sternal bone marrow in humans.
    Mertes PM; Voiriot P; Dopff C; Scholl H; Clavey M; Villemot JP; Canton P; Dureux JB
    Antimicrob Agents Chemother; 1990 Mar; 34(3):398-401. PubMed ID: 2185690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of intravenous vancomycin in pediatric cardiopulmonary bypass surgery.
    Hatzopoulos FK; Stile-Calligaro IL; Rodvold KA; Sullivan-Bolyai J; Del Nido P; Levitsky S
    Pediatr Infect Dis J; 1993 Apr; 12(4):300-4. PubMed ID: 8483624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose ranging study and constant infusion evaluation of ciprofloxacin.
    Drusano GL; Plaisance KI; Forrest A; Standiford HC
    Antimicrob Agents Chemother; 1986 Sep; 30(3):440-3. PubMed ID: 3777907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration in the pharmacokinetic disposition of ciprofloxacin by simultaneous administration of azlocillin.
    Barriere SL; Catlin DH; Orlando PL; Noe A; Frost RW
    Antimicrob Agents Chemother; 1990 May; 34(5):823-6. PubMed ID: 2360821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin sequestration during cardiopulmonary bypass surgery.
    Krivoy N; Yanovsky B; Kophit A; Zaher A; Bar-El Y; Adler Z; Gaitini L; Milo S
    J Infect; 2002 Aug; 45(2):90-5. PubMed ID: 12217710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ciprofloxacin pharmacokinetics in burn patients.
    Garrelts JC; Jost G; Kowalsky SF; Krol GJ; Lettieri JT
    Antimicrob Agents Chemother; 1996 May; 40(5):1153-6. PubMed ID: 8723457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steady-state pharmacokinetics of ciprofloxacin in plasma from patients with nosocomial pneumonia: penetration of the bronchial mucosa.
    Fabre D; Bressolle F; Gomeni R; Arich C; Lemesle F; Beziau H; Galtier M
    Antimicrob Agents Chemother; 1991 Dec; 35(12):2521-5. PubMed ID: 1810184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of ciprofloxacin in pediatric cystic fibrosis patients.
    Schaefer HG; Stass H; Wedgwood J; Hampel B; Fischer C; Kuhlmann J; Schaad UB
    Antimicrob Agents Chemother; 1996 Jan; 40(1):29-34. PubMed ID: 8787874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a population pharmacokinetic model and optimal sampling strategies for intravenous ciprofloxacin.
    Forrest A; Ballow CH; Nix DE; Birmingham MC; Schentag JJ
    Antimicrob Agents Chemother; 1993 May; 37(5):1065-72. PubMed ID: 8517693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous ciprofloxacin disposition in obesity.
    Allard S; Kinzig M; Boivin G; Sörgel F; LeBel M
    Clin Pharmacol Ther; 1993 Oct; 54(4):368-73. PubMed ID: 8222478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cardiopulmonary bypass on cefazolin disposition.
    Miller KW; McCoy HG; Chan KK; Fischer RP; Lindsay WG; Seifert RD; Zaske DE
    Clin Pharmacol Ther; 1980 Apr; 27(4):550-6. PubMed ID: 7357814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftriaxone disposition in open-heart surgery patients.
    Jungbluth GL; Pasko MT; Beam TR; Jusko WJ
    Antimicrob Agents Chemother; 1989 Jun; 33(6):850-6. PubMed ID: 2764536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships between renal function and disposition of oral ciprofloxacin.
    Forrest A; Weir M; Plaisance KI; Drusano GL; Leslie J; Standiford HC
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1537-40. PubMed ID: 3190182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of probenecid on the distribution and elimination of ciprofloxacin in humans.
    Jaehde U; Sörgel F; Reiter A; Sigl G; Naber KG; Schunack W
    Clin Pharmacol Ther; 1995 Nov; 58(5):532-41. PubMed ID: 7586947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alcuronium kinetics in patients undergoing cardiopulmonary bypass surgery.
    Walker JS; Brown KF; Shanks CA
    Br J Clin Pharmacol; 1983 Feb; 15(2):237-44. PubMed ID: 6601958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous pharmacokinetics of ciprofloxacin in goats.
    García Ovando H; Gorla N; Poloni G; Trotti N; Prieto G; Errecalde C
    Int J Antimicrob Agents; 2000 Jun; 15(1):77-9. PubMed ID: 10856681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition kinetics of ciprofloxacin in lactating goats.
    el-Banna HA; Abo el-Sooud K
    Dtsch Tierarztl Wochenschr; 1998 Jan; 105(1):35-8. PubMed ID: 9499632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative pharmacokinetics of intravenous ofloxacin and ciprofloxacin.
    Lode H; Höffken G; Olschewski P; Sievers B; Kirch A; Borner K; Koeppe P
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():73-9. PubMed ID: 3182465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steady-state pharmacokinetics of intravenous and oral ciprofloxacin in elderly patients.
    Hirata CA; Guay DR; Awni WM; Stein DJ; Peterson PK
    Antimicrob Agents Chemother; 1989 Nov; 33(11):1927-31. PubMed ID: 2610503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.